Roche pulls from Genentech well amid clinical trial issues, biosimilar competition


Group sales of Roche drugs rose 2% last year from 2021, the company said, to nearly $70 billion.

Previous Louisiana-based B1bank eyes more Houston growth following first year in market
Next Malpractice insurance specialist Constellation merges with N.C. health advisory firm Curi